Stock kasuwa, musayar ciniki a yau
Rahoton samfurori na kamfanonin 71229 a ainihin lokacin.
Stock kasuwa, musayar ciniki a yau

Rahoton samfurori

Stock ya faɗi a kan layi

Stock ya faɗi tarihi

Kasashen kasuwancin jari

Stock dividends

Riba daga kamfanin kamfanoni

Rahotan kuɗi

Ƙididdiga na kamfanoni. A ina zan zuba kudi?

Halozyme Therapeutics, Inc. kasuwar kasuwa

Matsayin kasuwancin jari na Halozyme Therapeutics, Inc. a yau da kuma tarihin ƙaddamar da Halozyme Therapeutics, Inc. daga farkon kasuwanci a HALO hannun jari akan musayar jari.
Ƙara zuwa widget din
Ƙara zuwa widget din

Halozyme Therapeutics, Inc. girma

Yau kasuwa kasuwa na Halozyme Therapeutics, Inc. shine 4 447 028 736 US dollar.
+71 769 600 $ (+1.64%)
canji na strongn kudi tun jiya

Canji a cikin kasuwancin Halozyme Therapeutics, Inc. shafin yanar gizon mu yana karɓar sau ɗaya a rana. Shafin yanar gizon mu yana ɗaukar bayani na Halozyme Therapeutics, Inc. ikon amfani da kai na yau daga hanyoyin bude. Bayani kan ikon mallaka na Halozyme Therapeutics, Inc. an yi don kawai ne kawai. Halozyme Therapeutics, Inc. kasuwar fila a yau ita ce $ 4 447 028 736.

Halozyme Therapeutics, Inc. girma na kasuwanci

Yau yaudarar kasuwancin jari Halozyme Therapeutics, Inc. ya kai 834 657 US dollar.
+671 034 $ (+410.11%)
canjin karuwar kasuwancin tun jiya

Halozyme Therapeutics, Inc. kundin ciniki na yau = = 834 657 dalar Amurka. Halozyme Therapeutics, Inc. an yi ciniki akan musayar jari daban-daban. Shafin yau da kullun na Halozyme Therapeutics, Inc. an gabatar da girman ciniki a shafin yanar gizon mu. Halozyme Therapeutics, Inc. hula kasuwar ke tafiya.

Nuna:
To

Halozyme Therapeutics, Inc. kasuwar kasuwa

Halozyme Therapeutics, Inc. ginshiƙi na kasuwar kwastomomi cikin shekaru. Canjin Halozyme Therapeutics, Inc. ikon mallaka a mako guda shine -2.44%. Halozyme Therapeutics, Inc. canjin tsarin sarauta na shekara shine 0%. A yau, Halozyme Therapeutics, Inc. ikon mallaka daidai yake da 4 447 028 736 dalar Amurka.

Week Watan 3 months Shekara 3 shekaru

Halozyme Therapeutics, Inc. tarihin lalata

Kwanan Girma
Babban jari (kasuwannin kasuwa) shine kasuwa na kasuwa na kamfanonin da ke sayarwa akan musayar jari. Mahimmancin kasuwancin yana daidai da farashin hannun jari da yawa ta hanyar yawan kuɗi.
03/05/2023 4 447 028 736 $
02/05/2023 4 375 259 136 $
01/05/2023 4 415 883 264 $
28/04/2023 4 381 014 016 $
27/04/2023 4 365 779 968 $
26/04/2023 4 449 737 216 $
25/04/2023 4 558 069 248 $

Halozyme Therapeutics, Inc. tashar girma

Week Watan 3 months Shekara 3 shekaru

Halozyme Therapeutics, Inc. bayanan tarihi na tarihi

Kwanan Volume (24h)
Ƙaramar kasuwancin Halozyme Therapeutics, Inc. hannun jari shine yawan yawan ma'amaloli tare da hannun jari na HALO da aka saya a lokacin da aka zaba.
03/05/2023 834 657 $
02/05/2023 163 623 $
01/05/2023 649 422 $
28/04/2023 252 791 $
27/04/2023 848 585 $
26/04/2023 395 741 $
25/04/2023 31 265 $

Halozyme Therapeutics, Inc. capitalization daidai yake da 4 447 028 736 Dalar Amurka a 03/05/2023. Halozyme Therapeutics, Inc. capitalization kasuwa shine $ 4 375 259 136 a 02/05/2023. Babban tsarin kasuwancin Halozyme Therapeutics, Inc. a 01/05/2023 wanda aka kimanta zuwa 4 415 883 264 dalar Amurka. Babban tsarin kasuwancin Halozyme Therapeutics, Inc. a 28/04/2023 wanda aka kimanta zuwa 4 381 014 016 dalar Amurka.

A 27/04/2023, Halozyme Therapeutics, Inc. taken kasuwa shine $ 4 365 779 968. Kasuwancin kasuwa na Halozyme Therapeutics, Inc. wanda aka ƙira zuwa 4 449 737 216 Dalar Amurka a 26/04/2023. 25/04/2023 Halozyme Therapeutics, Inc. ikon mallaka daidai yake da 4 558 069 248 dalar Amurka.

A capitalization na Halozyme Therapeutics, Inc. a yau shi ne 4 447 028 736 $. Girman kasuwa na Halozyme Therapeutics, Inc. ya canza zuwa +1.64% idan aka kwatanta da jiya. Hanyoyin ciniki na HALO hannun jari na Halozyme Therapeutics, Inc. a rana ta ƙarshe ta kasuwanci ya kasance 834 657 $. Ƙarin ciniki na Halozyme Therapeutics, Inc. ya canza zuwa +410.11% idan aka kwatanta da ranar ciniki.

Kudin hannun jari Halozyme Therapeutics, Inc.

Finance Halozyme Therapeutics, Inc.